Compound Detail
CHEMBL3577124
LY-3009120 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL3577124 |
| Name | LY-3009120 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | HHCBMISMPSAZBF-UHFFFAOYSA-N |
27
Targets
50
Activities
2
Assay Types
30
PK Parameters
20
Publications
4
Known Names
4
Indications
3
Mechanisms
Molecular Properties
424.5
MW (Da)
5.05
ALogP
5
HBA
3
HBD
91.8
PSA (Ų)
0.53
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serine/threonine-protein kinase B-raf inhibitor | INHIBITOR | Serine/threonine-protein kinase B-raf | ✓ | ✓ |
| Serine/threonine-protein kinase RAF inhibitor | INHIBITOR | RAF proto-oncogene serine/threonine-protein kinase | ✓ | ✓ |
| Serine/threonine-protein kinase A-Raf inhibitor | INHIBITOR | Serine/threonine-protein kinase A-Raf | ✓ | ✓ |
Indications
Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Melanoma Neoplasm Metastasis
Activity Summary
IC50 46 meas. best 8.92
Ki 4 meas. best 10.21
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| RAF proto-oncogene serine/threonine-protein kinase CHEMBL1906 | Ki | 10.21 | 10.21 | 0.1 | 2 |
| Serine/threonine-protein kinase B-raf CHEMBL5145 | Ki | 9.86 | 9.86 | 0.1 | 2 |
| Serine/threonine-protein kinase A-Raf CHEMBL1169596 | IC50 | 8.92 | 7.88 | 1.2 | 3 |
| Serine/threonine-protein kinase B-raf CHEMBL5145 | IC50 | 8.82 | 7.8875 | 1.5 | 8 |
| RAF proto-oncogene serine/threonine-protein kinase CHEMBL1906 | IC50 | 8.42 | 7.8875 | 3.8 | 4 |
| A-375 CHEMBL613859 | IC50 | 8.04 | 7.415 | 9.2 | 4 |
| Ephrin type-A receptor 2 CHEMBL2068 | IC50 | 7.7 | 7.7 | 20.0 | 1 |
| Mitogen-activated protein kinase kinase kinase 20 CHEMBL3886 | IC50 | 7.41 | 7.41 | 39.0 | 1 |
| A549 CHEMBL392 | IC50 | 7.34 | 6.8 | 45.6 | 4 |
| MAP kinase p38 CHEMBL2094115 | IC50 | 7.21 | 7.21 | 61.0 | 1 |
| Tyrosine-protein kinase Fyn CHEMBL1841 | IC50 | 7.04 | 7.04 | 91.0 | 1 |
| Mitogen-activated protein kinase kinase kinase 1 CHEMBL3956 | IC50 | 7.01 | 7.01 | 98.0 | 1 |
| MV4-11 CHEMBL613835 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| Ephrin type-B receptor 4 CHEMBL5147 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| GTPase KRas CHEMBL2189121 | IC50 | 6.82 | 6.82 | 150.0 | 1 |
| SK-MEL-2 CHEMBL614917 | IC50 | 6.7 | 6.7 | 200.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 6.66 | 6.66 | 220.0 | 1 |
| Tyrosine-protein kinase CSK CHEMBL2634 | IC50 | 6.54 | 6.54 | 290.0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src CHEMBL267 | IC50 | 6.51 | 6.51 | 310.0 | 1 |
| Tyrosine-protein kinase ABL1 CHEMBL1862 | IC50 | 6.42 | 6.42 | 380.0 | 1 |
| Interleukin-1 receptor-associated kinase 1 CHEMBL3357 | IC50 | 6.41 | 6.41 | 390.0 | 1 |
| eIF-2-alpha kinase GCN2 CHEMBL5358 | IC50 | 6.35 | 6.35 | 450.0 | 1 |
| c-Jun N-terminal kinase, JNK CHEMBL2096667 | IC50 | 6.33 | 6.33 | 470.0 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 5 CHEMBL4948 | IC50 | 6.1 | 6.1 | 800.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.05 | 6.05 | 900.0 | 1 |
| HT-29 CHEMBL384 | IC50 | 6.05 | 6.05 | 900.0 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 5 CHEMBL4852 | IC50 | 6.01 | 6.01 | 970.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 5.58 | 5.58 | 2600.0 | 1 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 5.41 | 5.41 | 3900.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 169.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 1667.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 20.5 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 2093.0 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 1260.0 | ng.hr.mL-1 | Macaca mulatta |
| CL | 34.1 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 14.6 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 25.9 | mL.min-1.kg-1 | Macaca mulatta |
| CL | 30.0 | % | Rattus norvegicus |
| CL | 30.0 | % | Canis lupus familiaris |
| CL | 30.0 | % | Macaca mulatta |
| Cmax | 81.03 | nM | Rattus norvegicus |
| Cmax | 932.82 | nM | Rattus norvegicus |
| Cmax | 6.596 | nM | Canis lupus familiaris |
| Cmax | 1203.71 | nM | Canis lupus familiaris |
| Cmax | 1158.96 | nM | Macaca mulatta |
| F | 3.6 | % | Rattus norvegicus |
| F | 31.7 | % | Rattus norvegicus |
| F | 0.2 | % | Canis lupus familiaris |
| F | 16.7 | % | Canis lupus familiaris |
| F | 20.0 | % | Macaca mulatta |
| T1/2 | 1.4 | hr | Rattus norvegicus |
| T1/2 | 2.7 | hr | Rattus norvegicus |
| T1/2 | 7.6 | hr | Canis lupus familiaris |
| T1/2 | 7.9 | hr | Canis lupus familiaris |
| T1/2 | 3.5 | hr | Macaca mulatta |
| T1/2 | 1.1 | hr | Rattus norvegicus |
| T1/2 | 1.8 | hr | Canis lupus familiaris |
| T1/2 | 1.0 | hr | Macaca mulatta |
| T1/2 | 67.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine